SCHEMBL13499161

SCHEMBL13499161

N[C@@H]1CC2(CCCC2)Oc2ccc(Br)cc21

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.36
IDO1 P14902 5/20 0.35
KDM1B Q8NB78 1/20 0.34
BACE1 P56817 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HTR2B P41595 2/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
APP P05067 1/20 0.32
AHR P35869 1/20 0.32
OPRD1 P41143 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619660 0.97 KDM1A (0.36) KDM1AIDO1KDM1BBACE1HTR2B
SCHEMBL4420243 0.82 HDAC3 (0.39) IDO1TRPV1LMNA
SCHEMBL13499163 0.82 HDAC3 (0.39) IDO1TRPV1LMNA
SCHEMBL4350339 0.82 KDM4E (0.48) KDM4EHTR2BHTTATMTRPV1
SCHEMBL3794790 0.82 KDM1A (0.37) KDM1AKDM4EHTTATMTRPV1
SCHEMBL3801092 0.81 KDM4E (0.36) KDM1AKDM4EHTR2BHTTATM
Hydrochloric Acid SCHEMBL6558690 0.81 TRPV1 (0.40) KDM1AKDM1BHTR2BTRPV1
Hydrochloric Acid SCHEMBL21979441 0.80 IDO1 (0.45) IDO1BACE1
Hydrochloric Acid SCHEMBL6559908 0.79 TRPV1 (0.39) KDM1AKDM1BTRPV1
SCHEMBL619444 0.79 HDAC3 (0.39) IDO1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662811-B2 N-(((5R)-5-((1-methylethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-1,2,3,4-tetrahydro-2-pyrazinyl)acetamide; for treatment of pain and diseases, such as inflammation mediated diseases AMGEN INC. (US) 2010-02-16 US disclosed
US-7662811-B2 N-(((5R)-5-((1-methylethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-1,2,3,4-tetrahydro-2-pyrazinyl)acetamide; for treatment of pain and diseases, such as inflammation mediated diseases AMGEN INC. (US) 2010-02-16 US disclosed